Figure 2From: Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patientsEvaluation of the final model: comparison between the 5th, 50th and 95th percentile obtained from 400 simulations (lines), and the observed data (o) for cysteamine concentrations standardized for a cysteamine dose of 900 mg/day (A) and for WBC cystine levels (B).Back to article page